Life and death on the posterior capsule

Article

The UK?s Professor John Marshall looks at the evolution of excimer delivery systems.

Whilst posterior capsule opacification (PCO) rates had been dramatically reduced in the past few years thanks to IOL design and development there was still a great deal of work to be done in addressing what remains the common complication following implant and cataract surgery, according to Dr David Spalton who delivered the Ridley Medal Lecture at ESCRS in Paris.

Life and death on the posterior capsule was the theme of his talk and he addressed the strides made since Harold Ridley implanted the very first IOL in 1949 from realizing that PCO was not an inevitable result of the procedure, that square edge profiles made a difference in prevention and that resistance was best offered by a 360 degree square edged barrier on the IOL so that lens ephithelial cells could not migrate across the optic-haptic onto the posterior capsule.

Dr Spalton also acknowledged that as the trend towards microincision surgery increased manufacturers were concentrating on developing thinner-edged lenses to insert in a small incision but this was at the expense of incorporating a 360 degree square edged barrier. He predicted that this trend would not be reversible and that the answer to further reduction in PCO rates would emerge from elsewhere. Research to achieve this currently includes isolation of the lens epithelial cells, a means of destroying them completely or removing them by means of an open bag device.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.